Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 5/20 | 0.83 |
| ▸ | CARM1 | Q86X55 | 4/20 | 0.83 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.68 |
| ▸ | CCR3 | P51677 | 4/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.62 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.62 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.61 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.61 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.60 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.60 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20467905 | 0.94 | PRMT6 (0.79) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| SCHEMBL10145310 | 0.91 | PRMT6 (1.00) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| SCHEMBL4786744 | 0.84 | CCR3 (0.67) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| SCHEMBL4777009 | 0.84 | CCR3 (0.65) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| SCHEMBL24075741 | 0.84 | CCR3 (0.65) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| SCHEMBL153896 | 0.83 | KCNH2 (0.88) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL7195898 | 0.83 | CCR3 (0.66) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL5756731 | 0.83 | CCR3 (0.66) | PRMT6CARM1KCNH2CCR3SIGMAR1 | |
| SCHEMBL18568473 | 0.82 | SLC6A2 (0.72) | CCR3SLC6A2SLC6A4TMEM97SLC6A3 | |
| SCHEMBL8966093 | 0.82 | PRMT6 (1.00) | PRMT6CARM1CCR3SIGMAR1TMEM97 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150368261-A1 | CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR | BIOINTEGRATOR LTD LIABILITY COMPANY (RU) | 2015-12-24 | — | — | US | disclosed |
| US-20150368261-A1 | CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR | BIOINTEGRATOR LTD LIABILITY COMPANY (RU) | 2015-12-24 | — | — | US | disclosed |
| WO-2009098282-A1 | LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY | NOVASAID AB (SE) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368261-A1 | CONJUGATES AND SMALL MOLECULES WHICH INTERACT WITH THE CD16A RECEPTOR | FCGR1A, FCGR2A, FCGR3B | PRMT6 1450/4885CARM1 993/4885KCNH2 3867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.